Karihtala, Peeter. 2025. “How to Choose Optimal Adjuvant Therapies for High-Risk Hormone Receptor-Positive, HER2-Negative Breast Cancer After Chemotherapy?”. Acta Oncologica 64 (June):815-29. https://doi.org/10.2340/1651-226X.2025.43645.